These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties. Gradauer K; Vonach C; Leitinger G; Kolb D; Fröhlich E; Roblegg E; Bernkop-Schnürch A; Prassl R Int J Nanomedicine; 2012; 7():2523-34. PubMed ID: 22679365 [TBL] [Abstract][Full Text] [Related]
4. S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties. Dünnhaupt S; Barthelmes J; Rahmat D; Leithner K; Thurner CC; Friedl H; Bernkop-Schnürch A Mol Pharm; 2012 May; 9(5):1331-41. PubMed ID: 22489677 [TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of an oral drug delivery system for peptides based on S-protected thiolated chitosan. Dünnhaupt S; Barthelmes J; Iqbal J; Perera G; Thurner CC; Friedl H; Bernkop-Schnürch A J Control Release; 2012 Jun; 160(3):477-85. PubMed ID: 22542699 [TBL] [Abstract][Full Text] [Related]
6. Mucus adhesion- and penetration-enhanced liposomes for paclitaxel oral delivery. Liu Y; Yang T; Wei S; Zhou C; Lan Y; Cao A; Yang J; Wang W Int J Pharm; 2018 Feb; 537(1-2):245-256. PubMed ID: 29288808 [TBL] [Abstract][Full Text] [Related]
7. Enhancing the Intestinal Permeation of the Chondroprotective Nutraceuticals Glucosamine Sulphate and Chondroitin Sulphate Using Conventional and Modified Liposomes. Agiba AM; Nasr M; Abdel-Hamid S; Eldin AB; Geneidi AS Curr Drug Deliv; 2018; 15(6):907-916. PubMed ID: 29359666 [TBL] [Abstract][Full Text] [Related]
8. Thiomer nanoparticles: stabilization via covalent cross-linking. Barthelmes J; Dünnhaupt S; Hombach J; Bernkop-Schnürch A Drug Deliv; 2011 Nov; 18(8):613-9. PubMed ID: 22111974 [TBL] [Abstract][Full Text] [Related]
9. Properties of liposomes coated with hydrophobically modified chitosan in oral liposomal drug delivery. Thongborisute J; Takeuchi H; Yamamoto H; Kawashima Y Pharmazie; 2006 Feb; 61(2):106-11. PubMed ID: 16526556 [TBL] [Abstract][Full Text] [Related]
10. The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin. Thongborisute J; Tsuruta A; Kawabata Y; Takeuchi H J Drug Target; 2006 Apr; 14(3):147-54. PubMed ID: 16753828 [TBL] [Abstract][Full Text] [Related]
11. Methylated N-(4-N,N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivery. Kowapradit J; Apirakaramwong A; Ngawhirunpat T; Rojanarata T; Sajomsang W; Opanasopit P Eur J Pharm Sci; 2012 Sep; 47(2):359-66. PubMed ID: 22771544 [TBL] [Abstract][Full Text] [Related]
12. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Takeuchi H; Yamamoto H; Niwa T; Hino T; Kawashima Y Pharm Res; 1996 Jun; 13(6):896-901. PubMed ID: 8792429 [TBL] [Abstract][Full Text] [Related]
14. Use of novel taurine-chitosan mediated liposomes for enhancing the oral absorption of doxorubicin via the TAUT transporter. Qin S; Wen Z; Huang H; Wu W Carbohydr Polym; 2024 Apr; 329():121780. PubMed ID: 38286550 [TBL] [Abstract][Full Text] [Related]
15. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Han HK; Shin HJ; Ha DH Eur J Pharm Sci; 2012 Aug; 46(5):500-7. PubMed ID: 22522117 [TBL] [Abstract][Full Text] [Related]
16. Improvement in physicochemical parameters of DPPC liposomes and increase in skin permeation of aciclovir and minoxidil by the addition of cationic polymers. Hasanovic A; Hollick C; Fischinger K; Valenta C Eur J Pharm Biopharm; 2010 Jun; 75(2):148-53. PubMed ID: 20332029 [TBL] [Abstract][Full Text] [Related]
17. The studies of N-Octyl-N-Arginine-Chitosan coated liposome as an oral delivery system of Cyclosporine A. Deng J; Zhang Z; Liu C; Yin L; Zhou J; Lv H J Pharm Pharmacol; 2015 Oct; 67(10):1363-70. PubMed ID: 26105005 [TBL] [Abstract][Full Text] [Related]
18. Chitosan-N-acetyl cysteine conjugates: in vitro evaluation of permeation enhancing and P-glycoprotein inhibiting properties. Schmitz T; Hombach J; Bernkop-Schnürch A Drug Deliv; 2008 May; 15(4):245-52. PubMed ID: 18446570 [TBL] [Abstract][Full Text] [Related]
19. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide. Iqbal J; Shahnaz G; Perera G; Hintzen F; Sarti F; Bernkop-Schnürch A Eur J Pharm Biopharm; 2012 Jan; 80(1):95-102. PubMed ID: 21964316 [TBL] [Abstract][Full Text] [Related]
20. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]